These effects, together with a past report exhibiting that a small-molecule ACKR3 agonist CCX771 displays anxiolytic-like behavior in mice,two support the strategy of targeting ACKR3 as a novel technique to modulate the opioid system, which could open new therapeutic avenues for opioid-related disorders. Can help to reduce Continual agony https://giordanoe442oav1.bloginder.com/profile